Income Statement (TTM)
Bolt Biotherapeutics, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 5 | 6 | 7 | 7 | 7 | 8 | 11 | 11 | 10 | 8 | 4 | 4 |
| Change (%) | -21.96 | -71.00 | -100.00 | ∞ | 67.55 | 64.52 | 67.20 | 39.24 | 18.71 | 17.68 | 0.59 | 6.13 | 9.42 | 43.78 | -1.40 | -12.42 | -21.36 | -52.69 | 14.54 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Cost Of Sales | 33 | 40 | 48 | 58 | 68 | 76 | 80 | 79 | 79 | 73 | 69 | 66 | 62 | 62 | 62 | 63 | 62 | 57 | 51 | 43 |
| Change (%) | 22.56 | 18.19 | 22.10 | 16.82 | 11.20 | 5.63 | -0.98 | -0.46 | -7.16 | -5.14 | -4.72 | -6.09 | -0.84 | 1.50 | 1.23 | -1.84 | -7.41 | -11.06 | -16.82 | |
| % of Revenue | 11,124.32 | 17,470.56 | 71,189.55 | 9,047.21 | 6,004.37 | 3,854.94 | 2,282.92 | 1,632.03 | 1,276.37 | 1,028.82 | 974.45 | 862.25 | 781.39 | 551.62 | 566.32 | 634.72 | 747.32 | 1,405.00 | 1,020.33 | |
| Gross Operating Profit | -33 | -40 | -48 | -58 | -67 | -74 | -78 | -76 | -74 | -67 | -63 | -59 | -55 | -54 | -51 | -52 | -52 | -50 | -47 | -38 |
| Change (%) | 22.97 | 18.70 | 22.27 | 15.53 | 10.57 | 4.63 | -2.80 | -2.28 | -8.85 | -7.08 | -5.30 | -7.48 | -2.19 | -4.70 | 1.81 | 0.42 | -4.80 | -4.63 | -19.22 | |
| % of Revenue | -11,024.32 | -17,370.56 | -71,089.55 | -8,947.21 | -5,904.37 | -3,754.94 | -2,182.92 | -1,532.03 | -1,176.37 | -928.82 | -874.45 | -762.25 | -681.39 | -451.62 | -466.32 | -534.72 | -647.32 | -1,305.00 | -920.33 | |
| SG&A | 9 | 9 | 11 | 13 | 15 | 18 | 20 | 22 | 22 | 23 | 22 | 22 | 23 | 23 | 23 | 22 | 20 | 18 | 16 | 15 |
| Change (%) | -0.86 | 24.04 | 18.19 | 15.64 | 19.81 | 10.90 | 7.25 | 2.49 | 2.26 | -3.00 | 0.40 | 1.23 | -0.32 | 0.98 | -3.28 | -8.91 | -7.91 | -10.90 | -8.26 | |
| % of Revenue | 3,086.15 | 3,920.35 | 16,765.67 | 2,041.49 | 1,459.76 | 983.98 | 631.16 | 464.57 | 400.19 | 329.86 | 329.22 | 314.02 | 286.06 | 200.91 | 197.06 | 204.96 | 240.01 | 452.03 | 362.06 | |
| R&D | 1 | -1 | ||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | 8.65 | -18.20 | ||||||||||||||||||
| OpEx | 42 | 49 | 59 | 72 | 83 | 94 | 100 | 101 | 101 | 96 | 92 | 88 | 85 | 84 | 86 | 85 | 82 | 76 | 67 | 58 |
| Change (%) | 17.47 | 19.26 | 21.35 | 16.60 | 12.78 | 6.66 | 0.69 | 0.18 | -5.07 | -4.63 | -3.48 | -4.24 | -0.70 | 2.53 | -1.11 | -3.67 | -7.53 | -11.89 | -13.89 | |
| % of Revenue | 14,210.47 | 21,390.91 | 87,955.22 | 11,088.70 | 7,464.13 | 4,838.93 | 2,914.08 | 2,096.60 | 1,676.56 | 1,358.68 | 1,303.67 | 1,176.27 | 1,067.45 | 761.19 | 763.38 | 839.68 | 987.33 | 1,838.84 | 1,382.39 | |
| Operating Income | -42 | -49 | -59 | -72 | -83 | -93 | -98 | -98 | -96 | -90 | -85 | -82 | -77 | -76 | -75 | -74 | -72 | -68 | -63 | -53 |
| Change (%) | 17.75 | 19.68 | 21.49 | 15.55 | 12.29 | 5.87 | -0.71 | -1.21 | -6.26 | -6.05 | -3.80 | -5.10 | -1.64 | -1.74 | -1.07 | -2.35 | -5.66 | -7.29 | -15.53 | |
| % of Revenue | -14,110.47 | -21,290.91 | -87,855.22 | -10,988.70 | -7,364.13 | -4,738.93 | -2,814.08 | -1,996.60 | -1,576.56 | -1,258.68 | -1,203.67 | -1,076.27 | -967.45 | -661.19 | -663.38 | -739.68 | -887.33 | -1,738.84 | -1,282.39 | |
| Interest Expense | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Net Income | -39 | -61 | -77 | -89 | -102 | -99 | -98 | -97 | -95 | -88 | -81 | -77 | -71 | -69 | -63 | -66 | -65 | -63 | -63 | -51 |
| Change (%) | 55.49 | 26.05 | 16.36 | 15.04 | -3.78 | -0.79 | -0.94 | -1.69 | -7.52 | -7.60 | -5.66 | -7.16 | -2.94 | -8.92 | 4.98 | -1.63 | -3.02 | 0.36 | -19.94 | |
| % of Revenue | -13,194.26 | -26,289.18 | -114,252.24 | -13,626.20 | -7,824.68 | -4,718.52 | -2,795.56 | -1,973.85 | -1,537.76 | -1,207.36 | -1,132.31 | -990.43 | -878.58 | -556.59 | -592.57 | -665.56 | -820.78 | -1,741.26 | -1,217.01 | |
Source: Capital IQ
